#BREAKING: The U.S. FDA has approved Soleno Therapeutics' diazoxide choline extended-release tablets, marketed as Vykat XR, for treating #PraderWilli syndrome in patients 4 years and older with #hyperphagia. neurologylive.com/view/fda-appro…

Thank you Marco Meglio and NeurologyLive® for the conversation at #ADPD2025.

During #ADPD2025, Mary Hamby, PhD sat down with Marco Meglio from NeurologyLive® to discuss #zervimesine’s potential impact in #alzheimers treatment. Watch their full interview here: neurologylive.com/view/assessing… #Dementia #DementiaWithLewyBodies #BiotechInnovation #ClinicalResearch

#BREAKING: The U.S. FDA approved a new pre-filled syringe administration route for efgartigimod a marketed medication for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. argenx hubs.li/Q03gWf8W0

We were excited to partner with @neurologylive on this excellent series of videos! In our 2nd episode, Vanessa Hinson, MD, PhD (MUSC Health), Carlayne Jackson, MD, FAAN, MD, FAAN (American Academy of Neurology), Marie Eugene, DO (UConn Health), and Marco Meglio discuss institutional policy changes that can

Women in #neurology face unique challenges, and Vanessa Hinson, MD, PhD (MUSC Health), Carlayne Jackson, MD, FAAN, MD, FAAN (American Academy of Neurology), and Marie Eugene, DO (UConn Health) spoke with Marco Meglio from NeurologyLive® about strategies to overcome underrepresentation in leadership roles,

AUPN partnered with NeurologyLive® on a video series exploring the perspectives of women in #neurology. In this video, Dr. Marie Eugene, Dr. Vanessa Hinson, & Dr. Carlayne Jackson, MD, FAAN shared their advice for early-career women in neurology. neurologylive.com/view/episode-4… Marco Meglio

#BREAKING: The U.S. FDA has approved Johnson & Johnson's nipocalimab, marketed as Imaavy, for the treatment of patients aged 12+ with myasthenia gravis for both anti-AChR and anti-MuSK forms🧠 More on the decision📲neurologylive.com/view/fda-appro…

#BREAKING: Last night, the U.S. FDA approved Satsuma's dihydroergotamine nasal powder agent STS101, marketed as Atzumi, as a new treatment for patients with acute #migraine with or without aura. hubs.li/Q03kCn0D0

In the final video of our Elevating Women in #Neurology series with NeurologyLive®, Drs. Marie Eugene, Vanessa Hinson, & Carlayne Jackson, MD, FAAN discussed key areas of women-focused neurology research, from inclusion in clinical trials to workforce challenges. neurologylive.com/view/episode-5…

Happy to share our review article about acute stroke therapeutics! doi.org/10.1136/bmj-20…

#DownSyndrome and #Alzheimer’s: Clinical Trials, Equity, and Patient-Centered Progress neurologylive.com/view/episode-1… by Marco Meglio NeurologyLive® #science #neuroscience

💡Great insights from Dr. Seif Elbualy on the expanding role of non-surgical interventional pain mgmt including percutaneous procedures and devices. via ⁦NeurologyLive®⁩ neurologylive.com/view/overviewi…

A must-attend session on refractory #status! #EEG #epilepsy International League Against Epilepsy yesILAE WashU Medicine Neurology tinyurl.com/ynp38s74

New 5-year findings from the National RLS Opioid Registry presented at #SLEEP2025 highlight the long-term stability and dose trends of low-dose opioid therapy in patients with restless legs syndrome (#RLS)🧠 Learn more: hubs.li/Q03t9nwD0

🧠 ICYMI: Dravet ≠ LGS. Dr. Joseph Sullivan, MD, breaks down how the two syndromes differ in seizure type, onset, genetic roots, and treatment strategies. This 10-minute listen can sharpen your diagnostic lens. 🎧 hubs.li/Q03w6wsV0

This was really fun to put together. For my neurology audience who specializes in sleep disorders, definitely a lot of great clinical nuggets you’re going to watch to check out!!

We're looking forward to our #AUPN2025 session on using #simulations to evaluate non-medical knowledge competencies like teaching, professionalism, and communication skills! Session Moderator Dr. Nuri Jacoby spoke with Marco Meglio from @NeurologyLive to give a short preview of

Marco Meglio Thank you for reporting on research released at #AAIC25 that shows a healthy lifestyle program targeting multiple risk factors can protect the cognitive function of at-risk older adults. neurologylive.com/view/structure…

How can we incorporate #AI to enhance #neurology education and clinical practice? Drs. Elisabeth Marsh, Raymond Price, and Rafael Llinas will be tackling this question in our upcoming #AUPN2025 Annual Meeting in Conjunction with the #ANA2025 Annual Meeting. Dr. Marsh joined